- Our Story
- In Memory
Wall Street Journal highlights McCance at TEDMED
Katherine Hobson features Cure Alzheimer's co-founder, Henry McCance and his TEDMED talk in the Wall Street Journal HealthBlog. She writes:
Henry McCance, chairman emeritus of venture-capital firm Greylock Partners, says the conventional way of funding academic research is ineffective. And he’s got an alternative strategy, based on how things work in the VC world. . .
McCance said, for every dollar spent on Alzheimer’s research, another $400 is spent on caregiving to those who suffer from the disease.
Researchers spend up to 30% of their time filling out grant applications, he said. The entire system encourages incremental research on already-established theories that moves the ball forward, at most, only a yard or two. With the Cure Alzheimer’s Fund, where McCance is a founding board member, there’s a different approach. Namely:
- Proactively identify world-class researchers and fund them.
- Relieve them from bureaucracy.
- Network researchers in a virtual organization and insist they share data and results promptly and collaboratively.
- Challenge your researchers to dare to be great.